These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A review of neuropathological and neurochemical correlates of Alzheimer's disease. Perry EK; Perry RH Dan Med Bull; 1985 Feb; 32 Suppl 1():27-34. PubMed ID: 2859148 [No Abstract] [Full Text] [Related]
26. The effects of Hydergine on neurotransmitters. Ermini M Br J Clin Pract Suppl; 1985 Jun; 39():11-5. PubMed ID: 2864053 [No Abstract] [Full Text] [Related]
27. Alzheimer's disease and the new neuroscience. Wortis J Biol Psychiatry; 1983 Aug; 18(8):847-8. PubMed ID: 6137248 [No Abstract] [Full Text] [Related]
28. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease. Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334 [TBL] [Abstract][Full Text] [Related]
29. Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia. Rossor MN; Iversen LL; Mountjoy CQ; Roth M; Hawthorn J; Ang VY; Jenkins JS Lancet; 1980 Dec 20-27; 2(8208-8209):1367-8. PubMed ID: 6109178 [No Abstract] [Full Text] [Related]
30. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease. Beal MF; MacGarvey U; Swartz KJ Ann Neurol; 1990 Aug; 28(2):157-61. PubMed ID: 1699471 [TBL] [Abstract][Full Text] [Related]
31. Possible biochemical basis of memory disorder in Alzheimer disease. Smith CM; Swash M Ann Neurol; 1978 Jun; 3(6):471-3. PubMed ID: 209723 [TBL] [Abstract][Full Text] [Related]
33. [Pathophysiology of senile dementia]. Karobath M Schweiz Med Wochenschr; 1985 Dec; 115(50):1803-7. PubMed ID: 2868521 [TBL] [Abstract][Full Text] [Related]
34. [Changes in neurotransmitters in Alzheimer-type dementia]. Nakamura S; Nakano S; Koshimura K Nihon Ronen Igakkai Zasshi; 1988 Jul; 25(4):358-63. PubMed ID: 2907920 [No Abstract] [Full Text] [Related]
35. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Perry EK; Marshall E; Perry RH; Irving D; Smith CJ; Blessed G; Fairbairn AF Alzheimer Dis Assoc Disord; 1990; 4(2):87-95. PubMed ID: 2357341 [TBL] [Abstract][Full Text] [Related]
37. MR features of the substantia innominata and therapeutic implications in dementias. Hanyu H; Shimizu S; Tanaka Y; Hirao K; Iwamoto T; Abe K Neurobiol Aging; 2007 Apr; 28(4):548-54. PubMed ID: 16569466 [TBL] [Abstract][Full Text] [Related]
38. Hyperinnervation of surviving neurons of the human basal nucleus of meynert by galanin in dementias of Alzheimer's and Parkinson's disease. Chan-Palay V Adv Neurol; 1990; 51():253-5. PubMed ID: 1688477 [No Abstract] [Full Text] [Related]
39. Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type. Rossor MN; Rehfeld JF; Emson PC; Mountjoy CQ; Roth M; Iversen LL Life Sci; 1981 Jul; 29(4):405-10. PubMed ID: 7278494 [No Abstract] [Full Text] [Related]